Skip to main content
View expanded cover

Mitochondrial Genetics and Cancer pp 39–66Cite as

The Warburg Phenomenon and Other Metabolic Alterations of Cancer Cells

Abstract

The altered metabolism of cancer cells was recognized and pioneered by the elegant works of Otto Warburg in the 1920s and popularized in the 1950s. Presently, it is well recognized that over sixty percent of all cancers are glycolytic. The Warburg effect or phenomenon is discussed, and the molecular understanding of some of Warburg’s statements is provided with regard to modern knowledge of carcinogenesis. In addition, molecular explanation of aerobic glycolysis of the cancer cell is detailed. Other metabolic alterations of the cancer cell including glutaminolysis and lipogenesis are discussed. The altered citrate metabolism specifically associated with malignant transformation of peripheral zone prostate epithelial cells, and the potential clinical applications of such metabolic alterations conclude this chapter.

Keywords

  • Aerobic Glycolysis
  • Fumarate Hydratase
  • Glutamine Metabolism
  • Citrate Transport Protein
  • Citrate Oxidation

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-642-11416-8_2
  • Chapter length: 28 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   179.00
Price excludes VAT (USA)
  • ISBN: 978-3-642-11416-8
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   229.99
Price excludes VAT (USA)
Hardcover Book
USD   279.99
Price excludes VAT (USA)
Learn about institutional subscriptions
Fig. 2.1
Fig. 2.2
Fig. 2.3

Notes

  1. 1.

    Grana refers to mitochondria.

References

  • Altenberg B, and Greulich KO (2004). Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84, 1014–1020.

    CAS  CrossRef  PubMed  Google Scholar 

  • Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, and Regev A (2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 40, 499–507.

    CAS  CrossRef  PubMed  Google Scholar 

  • Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, and Bartrons R (2006). TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126, 107–120.

    CAS  CrossRef  PubMed  Google Scholar 

  • Billin AN, Eilers AL, Queva C, and Ayer DE (1999). Mlx, a novel Max-like BHLHZip protein that interacts with the Max network of transcription factors. J Biol Chem 274, 36344–36350

    CAS  CrossRef  PubMed  Google Scholar 

  • Billin AN, Eilers AL, Coulter KL, Logan JS, and Ayer DE (2000). MondoA, a novel basic helix-loop-helix-leucine zipper transcriptional activator that constitutes a positive branch of a max-like network. Mol Cell Biol 20, 8845–8854.

    CAS  CrossRef  PubMed  Google Scholar 

  • Brown GK (2000). Glucose transporters: structure, function and consequences of deficiency. J Inherit Metab Dis 23, 237–246.

    CAS  CrossRef  PubMed  Google Scholar 

  • Bustamante E, and Pedersen PL (1977). High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci USA 74, 3735–3739.

    CAS  CrossRef  PubMed  Google Scholar 

  • Cai Z, and Semenza GL (2005). PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circ Res 97, 1351–1359.

    CAS  CrossRef  PubMed  Google Scholar 

  • Costello LC, and Franklin RB (2000). The intermediary metabolism of the prostate:a key to understanding the pathogenesis and progression of prostate malignancy. Oncology 59, 269–282.

    CAS  CrossRef  PubMed  Google Scholar 

  • Costello LC, and Franklin RB (2006). The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 5, 17.

    CrossRef  PubMed  Google Scholar 

  • Costello LC, and Franklin RB (2009). Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problem. Prostate Cancer Prostatic Dis 12, 17–24.

    CAS  CrossRef  PubMed  Google Scholar 

  • Costello LC, Franklin RB, and Narayan P (1999). Citrate in the diagnosis of prostate cancer. Prostate 38, 237–245.

    CAS  CrossRef  PubMed  Google Scholar 

  • Costello LC, Feng P, Milon B, Tan M, and Franklin RB (2004). Role of zinc in the pathogenesis and treatment of prostate cancer: critical issues to resolve. Prostate Cancer Prostatic Dis 7, 111–117.

    CAS  CrossRef  PubMed  Google Scholar 

  • Costello LC, Franklin RB, Feng P, Tan M, and Bagasra O (2005). Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States). Cancer Causes Control 16, 901–915.

    CrossRef  PubMed  Google Scholar 

  • Crabtree HG (1926). Observations on the carbohydrate metabolism of tumours. Biochem J 23, 536–545.

    Google Scholar 

  • Dahia PL, Ross KN, Wright ME, et al. (2005). A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet 1, 72–80.

    CAS  CrossRef  PubMed  Google Scholar 

  • DeBerardinis RJ, Mancuso A, Daikhin E, et al. (2007). Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 104, 19345–19350.

    CAS  CrossRef  PubMed  Google Scholar 

  • Desouki MM, Geradts J, Milon B, Franklin RB, and Costello LC (2007). hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands. Mol Cancer 6, 37.

    CrossRef  PubMed  Google Scholar 

  • Feng P, Li T, Guan Z, Franklin RB, and Costello LC (2008). The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells. Mol Cancer 7, 25.

    CrossRef  PubMed  Google Scholar 

  • Franklin RB, and Costello LC (2007). Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys 463, 211–217.

    CAS  CrossRef  PubMed  Google Scholar 

  • Franklin RB, and Costello LC (2009). The important role of the apoptotic effects of zinc in the development of cancers. J Cell Biochem 106, 750–757.

    CAS  CrossRef  PubMed  Google Scholar 

  • Fukuda R, Zhang H, Kim JW, et al. (2007). HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129, 111–122.

    CAS  CrossRef  PubMed  Google Scholar 

  • Gallus S, Foschi R, Negri E, et al. (2007). Dietary zinc and prostate cancer risk: a case-control study from Italy. Eur Urol 52, 1052–1056.

    CAS  CrossRef  PubMed  Google Scholar 

  • Gonzalez A, Peters U, Lampe JW, and White E (2009). Zinc intake from supplements and diet and prostate cancer. Nutr Cancer 61, 206–215.

    CAS  CrossRef  PubMed  Google Scholar 

  • Guzy RD, Hoyos B, Robin E, et al. (2005). Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1, 401–408.

    CAS  CrossRef  PubMed  Google Scholar 

  • Guzy RD, Sharma B, Bell E, Chandel NS, and Schumacker PT (2008). Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis. Mol Cell Biol 28, 718–731.

    CAS  CrossRef  PubMed  Google Scholar 

  • Harman D (1956). Aging: a theory based on free radical and radiation chemistry. J Gerontol 11, 298–300.

    CAS  PubMed  Google Scholar 

  • Hausenloy DJ, Tsang A, Mocanu MM, and Yellon DM (2005). Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288, H971–976.

    CrossRef  Google Scholar 

  • Heinz A, Sachs G, and Schafer JA (1981). Evidence for activation of an active electrogenic proton pump in Ehrlich ascites tumor cells during glycolysis. J Membr Biol 61, 143–153.

    CAS  CrossRef  PubMed  Google Scholar 

  • Hu CJ, Sataur A, Wang L, Chen H, and Simon MC (2007). The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell 18, 4528–4542.

    CAS  CrossRef  PubMed  Google Scholar 

  • Jiang BH, Agani F, Passaniti A, and Semenza GL (1997). V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 57, 5328–5335.

    CAS  PubMed  Google Scholar 

  • Jung JA, Coakley FV, Vigneron DB, et al. (2004). Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology 233, 701–708.

    CrossRef  PubMed  Google Scholar 

  • Kaelin WG, Jr. (2002). Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2, 673–682.

    CAS  CrossRef  PubMed  Google Scholar 

  • Kaelin WG (2005). The von Hippel-Lindau tumor suppressor protein: roles in cancer and oxygen sensing. Cold Spring Harb Symp Quant Biol 70, 159–166.

    CAS  CrossRef  PubMed  Google Scholar 

  • Kim JW, and Dang CV (2005). Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 30, 142–150.

    CAS  CrossRef  PubMed  Google Scholar 

  • Klimova T, and Chandel NS (2008). Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ 15, 660–666.

    CAS  CrossRef  PubMed  Google Scholar 

  • Kondoh H, Lleonart ME, Bernard D, and Gil J (2007). Protection from oxidative stress by enhanced glycolysis; a possible mechanism of cellular immortalization. Histol Histopathol 22, 85–90.

    CAS  PubMed  Google Scholar 

  • Koukourakis MI, Giatromanolaki A, Sivridis E, Gatter KC, and Harris AL (2005). Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia 7, 1–6.

    CAS  CrossRef  PubMed  Google Scholar 

  • Laughner E, Taghavi P, Chiles K, Mahon PC, and Semenza GL (2001). HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21, 3995–4004.

    CAS  CrossRef  PubMed  Google Scholar 

  • Li F, Wang Y, Zeller KI, et al. (2005). Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol 25, 6225–6234.

    CAS  CrossRef  PubMed  Google Scholar 

  • Linehan WM, Walther MM, and Zbar B (2003). The genetic basis of cancer of the kidney. J Urol 170, 2163–2172.

    CAS  CrossRef  PubMed  Google Scholar 

  • Lopez-Rios F, Sanchez-Arago M, Garcia-Garcia E, et al. (2007). Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas. Cancer Res 67, 9013–9017.

    CAS  CrossRef  PubMed  Google Scholar 

  • Lu H, Dalgard CL, Mohyeldin A, et al. (2005). Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 280, 41928–41939.

    CAS  CrossRef  PubMed  Google Scholar 

  • Mathupala SP, Rempel A, and Pedersen PL (1997). Aberrant glycolytic metabolism of cancer cells: a remarkable coordination of genetic, transcriptional, post-translational, and mutational events that lead to a critical role for type II hexokinase. J Bioenerg Biomembr 29, 339–343.

    CAS  CrossRef  PubMed  Google Scholar 

  • Mathupala SP, Ko YH, and Pedersen PL (2006). Hexokinase II: cancer's double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria. Oncogene 25, 4777–4786.

    CAS  CrossRef  PubMed  Google Scholar 

  • Matoba S, Kang JG, Patino WD, et al. (2006). p53 regulates mitochondrial respiration. Science 312, 1650–1653.

    CAS  CrossRef  PubMed  Google Scholar 

  • Mayer D, Klimek F, Rempel A, and Bannasch P (1997). Hexokinase expression in liver preneoplasia and neoplasia. Biochem Soc Trans 25, 122–127.

    CAS  PubMed  Google Scholar 

  • Maynard MA, and Ohh M (2004). Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer. Am J Nephrol 24, 1–13.

    CAS  CrossRef  PubMed  Google Scholar 

  • McFate T, Mohyeldin A, Lu H, et al. (2008). Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. J Biol Chem 283, 22700–22708.

    CAS  CrossRef  PubMed  Google Scholar 

  • Miquel J, Binnard R, and Fleming JE (1983). Role of metabolic rate and DNA-repair in Drosophila aging: implications for the mitochondrial mutation theory of aging. Exp Gerontol 18, 167–171.

    CAS  CrossRef  PubMed  Google Scholar 

  • Mocanu MM, Bell RM, and Yellon DM (2002). PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol 34, 661–668.

    CAS  CrossRef  PubMed  Google Scholar 

  • Moro L, Arbini AA, Yao JL, et al. (2008). Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2. Cell Death Differ.

    Google Scholar 

  • Murry CE, Jennings RB, and Reimer KA (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124–1136.

    CAS  PubMed  Google Scholar 

  • Ogawa Y, Kobayashi T, Nishioka A, et al. (2003). Radiation-induced reactive oxygen species formation prior to oxidative DNA damage in human peripheral T cells. Int J Mol Med 11, 149–152.

    CAS  PubMed  Google Scholar 

  • Osthus RC, Shim H, Kim S, et al. (2000). Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem 275, 21797–21800.

    CAS  CrossRef  PubMed  Google Scholar 

  • Papandreou I, Cairns RA, Fontana L, Lim AL, and Denko NC (2006). HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 3, 187–197.

    CAS  CrossRef  PubMed  Google Scholar 

  • Patel MS, and Korotchkina LG (2001). Regulation of mammalian pyruvate dehydrogenase complex by phosphorylation: complexity of multiple phosphorylation sites and kinases. Exp Mol Med 33, 191–197.

    CAS  PubMed  Google Scholar 

  • Pedersen PL (2007). Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 39, 211–222.

    CAS  CrossRef  PubMed  Google Scholar 

  • Pedersen PL, Mathupala S, Rempel A, Geschwind JF, and Ko YH (2002). Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta 1555, 14–20.

    CAS  CrossRef  PubMed  Google Scholar 

  • Plas DR, and Thompson CB (2005). Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24, 7435–7442.

    CAS  CrossRef  PubMed  Google Scholar 

  • Pollard P, Wortham N, Barclay E, et al. (2005a). Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome. J Pathol 205, 41–49.

    CrossRef  PubMed  Google Scholar 

  • Pollard PJ, Briere JJ, Alam NA, et al. (2005b). Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14, 2231–2239.

    CAS  CrossRef  PubMed  Google Scholar 

  • Pomare EW, Branch WJ, and Cummings JH (1985). Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood. J Clin Invest 75, 1448–1454.

    CAS  CrossRef  PubMed  Google Scholar 

  • Prahl S, Kueper T, Biernoth T, et al. (2008). Aging skin is functionally anaerobic: importance of coenzyme Q10 for anti aging skin care. Biofactors 32, 245–255.

    CAS  CrossRef  PubMed  Google Scholar 

  • Prando A, Kurhanewicz J, Borges AP, Oliveira EM, Jr., and Figueiredo E (2005). Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 236, 903–910.

    CrossRef  PubMed  Google Scholar 

  • Rempel A, Bannasch P, and Mayer D (1994). Differences in expression and intracellular distribution of hexokinase isoenzymes in rat liver cells of different transformation stages. Biochim Biophys Acta 1219, 660–668.

    PubMed  Google Scholar 

  • Rodriguez-Enriquez S, Juarez O, Rodriguez-Zavala JS, and Moreno-Sanchez R (2001). Multisite control of the Crabtree effect in ascites hepatoma cells. Eur J Biochem 268, 2512–2519.

    CAS  CrossRef  PubMed  Google Scholar 

  • Sans CL, Satterwhite DJ, Stoltzman CA, Breen KT, and Ayer DE (2006). MondoA-Mlx heterodimers are candidate sensors of cellular energy status: mitochondrial localization and direct regulation of glycolysis. Mol Cell Biol 26, 4863–4871.

    CAS  CrossRef  PubMed  Google Scholar 

  • Schofield CJ, and Ratcliffe PJ (2005). Signalling hypoxia by HIF hydroxylases. Biochem Biophys Res Commun 338, 617–626.

    CAS  CrossRef  PubMed  Google Scholar 

  • Semenza GL, and Wang GL (1992). A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12, 5447–5454.

    CAS  PubMed  Google Scholar 

  • Sheta EA, Trout H, Gildea JJ, Harding MA, and Theodorescu D (2001). Cell density mediated pericellular hypoxia leads to induction of HIF-1alpha via nitric oxide and Ras/MAP kinase mediated signaling pathways. Oncogene 20, 7624–7634.

    CAS  CrossRef  PubMed  Google Scholar 

  • Simon MC (2006). Mitochondrial reactive oxygen species are required for hypoxic HIF alpha stabilization. Adv Exp Med Biol 588, 165–170.

    CrossRef  PubMed  Google Scholar 

  • Singh KK, Desouki MM, Franklin RB, and Costello LC (2006). Mitochondrial aconitase and citrate metabolism in malignant and nonmalignant human prostate tissues. Mol Cancer 5, 14.

    CrossRef  PubMed  Google Scholar 

  • Sussman I, Erecinska M, and Wilson DF (1980). Regulation of cellular energy metabolism: the Crabtree effect. Biochim Biophys Acta 591, 209–223.

    CAS  CrossRef  PubMed  Google Scholar 

  • Tian H, McKnight SL, and Russell DW (1997). Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11, 72–82.

    CAS  CrossRef  PubMed  Google Scholar 

  • Tong H, Chen W, Steenbergen C, and Murphy E (2000). Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 87, 309–315.

    CAS  PubMed  Google Scholar 

  • Uddin S, Siraj AK, Al-Rasheed M, et al. (2008). Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers. J Clin Endocrinol Metab 93, 4088–4097.

    CAS  CrossRef  PubMed  Google Scholar 

  • Umbehr M, Bachmann LM, Held U, et al. (2008). Combined Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy Imaging in the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol.

    Google Scholar 

  • Vanharanta S, Pollard PJ, Lehtonen HJ, et al. (2006). Distinct expression profile in fumarate-hydratase-deficient uterine fibroids. Hum Mol Genet 15, 97–103.

    CAS  CrossRef  PubMed  Google Scholar 

  • Warburg O (1956). On the origin of cancer cells. Science 123, 309–314.

    CAS  CrossRef  PubMed  Google Scholar 

  • Wilson JE (1997). An introduction to the isoenzymes of mammalian hexokinase types I-III. Biochem Soc Trans 25, 103–107.

    CAS  PubMed  Google Scholar 

  • Wilson JE (2003). Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol 206, 2049–2057.

    CAS  CrossRef  PubMed  Google Scholar 

  • Wise DR, DeBerardinis RJ, Mancuso A, et al. (2008). Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 105, 18782–18787.

    CAS  CrossRef  PubMed  Google Scholar 

  • Wojtczak L (1996). The Crabtree effect: a new look at the old problem. Acta Biochim Pol 43, 361–368.

    CAS  PubMed  Google Scholar 

  • Yang X, Borg LA, and Eriksson UJ (1997). Altered metabolism and superoxide generation in neural tissue of rat embryos exposed to high glucose. Am J Physiol 272, E173–180.

    Google Scholar 

  • Zakian KL, Sircar K, Hricak H, et al. (2005). Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234, 804–814.

    CrossRef  PubMed  Google Scholar 

  • Zhang H, Gao P, Fukuda R, et al. (2007). HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11, 407–420.

    CAS  CrossRef  PubMed  Google Scholar 

  • Zhao ZQ, Corvera JS, Halkos ME, et al. (2003). Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285, H579–588.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Genesis Genomics, Inc., 290 Munro Street, Thunder Bay, ON, P7A 7T1, Canada

    Gabriel D. Dakubo

Authors
  1. Gabriel D. Dakubo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gabriel D. Dakubo .

Rights and permissions

Reprints and Permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dakubo, G.D. (2010). The Warburg Phenomenon and Other Metabolic Alterations of Cancer Cells. In: Mitochondrial Genetics and Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11416-8_2

Download citation